Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "Acta Clinica Belgica"
DOI: 10.1080/17843286.2017.1412888
Abstract: Abstract Objectives and Methods: High-grade B-cell lymphoma, NOS (HGBL) have an aggressive clinical behavior and poor outcome using regimens currently employed for diffuse large B-cell lymphoma (DLBCL) such as rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone… read more here.
Keywords: vncop; high grade; grade cell; cell ... See more keywords